ZCA
TNDM icon

Zeke Capital Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Zeke Capital Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,836
Closed -$208K – 314
2020
Q3 		$208K Buy
+1,836
New +$193K 0.02% 211

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Zeke Capital Advisors's TNDM Position: Q4 2020 in Review

Zeke Capital Advisors sold out of Tandem Diabetes Care (TNDM) in Q4 2020, closing a stake of 1,836 shares — an estimated $208K sold.

Zeke Capital Advisors first reported a position in TNDM in Q3 2020 and held it in 1 quarter. The position peaked at $208K in Q3 2020. 309 funds tracked by Wall St. Rank hold TNDM as of Q4 2020.

  • Zeke Capital Advisors reported no remaining Tandem Diabetes Care position as of Q4 2020 after selling out during the quarter.
  • Zeke Capital Advisors sold 1,836 Tandem Diabetes Care shares in Q4 2020, an estimated $208K.
  • Zeke Capital Advisors first reported a position in Tandem Diabetes Care in Q3 2020 and held it in 1 quarter.
  • Zeke Capital Advisors's Tandem Diabetes Care position peaked at $208K in Q3 2020.
  • 309 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2020.

Based on Zeke Capital Advisors's 13F filing for Q4 2020, filed 10 Feb 2021.